He, S., Lei, P., Kang, W., Cheung, P., Xu, T., Mana, M., ... & Saeidi, N. (2023). Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells. Gastroenterology, 164(7), 1137-1151.

Lahiri, A., Walton, J. C., Zhang, N., Billington, N., DeVries, A. C., & Meares, G. P. (2023). Astrocytic deletion of protein kinase r‐like <scp>er</scp> kinase (<scp>perk</scp>) does not affect learning and memory in aged mice but worsens outcome from experimental stroke. Journal of Neuroscience Research, 101(10), 1586–1610. https://doi.org/10.1002/jnr.25224

Kurata, K., Samur, M. K., Liow, P., Wen, K., Yamamoto, L., Liu, J., ... & Anderson, K. C. (2023). BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical Cancer Research, 29(9), 1807-1821.

Wang, D., Li, Y., Deng, X., Torre, M., Zhang, Z., Li, X., Zhang, W., Cullion, K., Kohane, D. S., & Weldon, C. B. (2023). An aptamer-based depot system for sustained release of Small Molecule Therapeutics. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-37002-0

Jimenez-Rondan, F. R., Ruggiero, C. H., McKinley, K. L., Koh, J., Roberts, J. F., Triplett, E. W., & Cousins, R. J. (2023). Enterocyte-specific deletion of metal transporter Zip14 (Slc39a14) alters intestinal homeostasis through epigenetic mechanisms. American Journal of Physiology-Gastrointestinal and Liver Physiology, 324(3), G159-G176.

Mercau, M. E., Akalu, Y. T., Mazzoni, F., Gyimesi, G., Alberto, E. J., Kong, Y., ... & Ghosh, S. (2023). Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in Mertk-associated retinitis pigmentosa. Science Advances, 9(3), eade9459.

Shore, D., Griggs, N., Graffeo, V., Amin, A. R., Zha, X.-ming, Xu, Y., & McAleer, J. P. (2023). GPR68 limits the severity of chemical-induced oral epithelial dysplasia. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-27546-y

Benchama, O., Malamas, M. S., Praveen, K., Ethier, E. C., Williams, M. K., Makriyannis, A., & Avraham, H. K. (2022). Inhibition of triple negative breast cancer-associated inflammation and progression by n- acylethanolamine acid amide hydrolase (NAAA). Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-26564-6

Lahiri, A., Walton, J. C., Zhang, N., Billington, N., DeVries, A. C., & Meares, G. P. (2023). Astrocytic deletion of protein kinase r‐like <scp>er</scp> kinase (<scp>perk</scp>) does not affect learning and memory in aged mice but worsens outcome from experimental stroke. Journal of Neuroscience Research, 101(10), 1586–1610. https://doi.org/10.1002/jnr.25224

Zhou, Y., Hou, D., Marigo, C. C., Bonelli, J., Rocas, P., Cheng, F., Yang, X., Rocas, J., Hamberg, N. M., & Han, J. (2022). Redox-responsive polyurethane-polyurea nanoparticles targeting to aortic endothelium and atherosclerosis. IScience, 25(11), 105390. https://doi.org/10.1016/j.isci.2022.105390

Huang, Z., You, X., Chen, L., Du, Y., Brodeur, K., Jee, H., Wang, Q., Linder, G., Darbousset, R., Cunin, P., Chang, M. H., Wactor, A., Wauford, B. M., Todd, M. J., Wei, K., Li, Y., Levescot, A., Iwakura, Y., Pascual, V., … Lee, P. Y. (2022). MTORC1 links pathology in experimental models of still’s disease and macrophage activation syndrome. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34480-6

Akalu, Y. T., Mercau, M. E., Ansems, M., Hughes, L. D., Nevin, J., Alberto, E. J., Liu, X. N., He, L.-Z., Alvarado, D., Keler, T., Kong, Y., Philbrick, W. M., Bosenberg, M., Finnemann, S. C., Iavarone, A., Lasorella, A., Rothlin, C. V., & Ghosh, S. (2022). Tissue-specific modifier alleles determine mertk loss-of-function traits. ELife, 11. https://doi.org/10.7554/elife.80530

Fang, L., Ford-Roshon, D., Russo, M., O’Brien, C., Xiong, X., Gurjao, C., Grandclaudon, M., Raghavan, S., Corsello, S. M., Carr, S. A., Udeshi, N. D., Berstler, J., Sicinska, E., Ng, K., & Giannakis, M. (2022). RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mtor inhibition. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30794-7

Li, Wanjin, et al. “Nuclear Ripk1 Promotes Chromatin Remodeling to Mediate Inflammatory Response.” Cell Research, 2022, https://doi.org/10.1038/s41422-022-00673-3.

Wu, Q., Zhen, Y., Shi, L., Vu, P., Greninger, P., Adil, R., Merritt, J., Egan, R., Wu, M.J., Yin, X. and Ferrone, C.R., 2022. EGFR inhibition potentiates FGFR inhibitor therapy and overcomes resistance in FGFR2 fusion-positive cholangiocarcinomaCombination Treatment in FGFR2-Fusion Cholangiocarcinoma. Cancer Discovery.

Wu, M.J., Shi, L., Dubrot, J., Merritt, J., Vijay, V., Wei, T.Y., Kessler, E., Olander, K.E., Adil, R., Pankaj, A. and Tummala, K.S., 2021. Mutant-IDH inhibits Interferon-TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma. Cancer discovery.

Anerillas, C., Herman, A. B., Munk, R., Garrido, A., Lam, K.-W. G., Payea, M. J., Rossi, M., Tsitsipatis, D., Martindale, J. L., Piao, Y., Mazan-Mamczarz, K., Fan, J., Cui, C.-Y., De, S., Abdelmohsen, K., de Cabo, R., & Gorospe, M. (2022). A BDNF-TrkB autocrine loop enhances senescent cell viability. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33709-8

Han, H., Li, S., Chen, T., Fitzgerald, M., Liu, S., Peng, C., Tang, K.H., Cao, S., Chouitar, J., Wu, J. and Peng, D., 2021. Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib. Cancer research, 81(20), pp.5311-5324.

Gonzalvez, F., Vincent, S., Baker, T.E., Gould, A.E., Li, S., Wardwell, S.D., Nadworny, S., Ning, Y., Zhang, S., Huang, W.S. and Hu, Y., 2021. Mobocertinib (TAK-788): a targeted inhibitor of EGFR exon 20 insertion mutants in non–small cell lung cancer. Cancer discovery, 11(7), pp.1672-1687.

Allouche, J., Rachmin, I., Adhikari, K., Pardo, L.M., Lee, J.H., McConnell, A.M., Kato, S., Fan, S., Kawakami, A., Suita, Y. and Wakamatsu, K., 2021. NNT mediates redox-dependent pigmentation via a UVB-and MITF-independent mechanism. Cell, 184(16), pp.4268-4283.

Kitamura, Y., Kanaya, N., Moleirinho, S., Du, W., Reinshagen, C., Attia, N., Bronisz, A., Revai Lechtich, E., Sasaki, H., Mora, J.L. and Brastianos, P.K., 2021. Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Science Advances, 7(10), p.eabe8671.